期刊文献+

肢体恶性黑色素瘤的外科治疗 被引量:10

Surgical treatment for malignant melanoma of extremity
原文传递
导出
摘要 目的探讨外科治疗在肢体恶性黑色素瘤中的临床作用。方法回顾性分析1993年8月-2007年12月就诊于我院骨肿瘤科22例肢体恶性黑色素瘤病例。男性12例,女性10例;年龄20-73岁,平均50.1岁;发病部位足底14例,足背1例,第二足趾1例,拇指甲下2例,腹股沟、大腿、膝部软组织各1例,胫骨1例。按照AJCC外科分期,Ⅱ期8例,Ⅲ期12例,Ⅳ期2例。保肢14例,截肢(趾)8例;保肢病例中局部切除后采用游离植皮或转移皮瓣重建10例,胫骨病变1例采用瘤段截除、人工关节置换术。外科边界:边缘切除4例,广泛切除14例,根治性切除4例。二期行区域淋巴结清扫14例。术后辅助达卡巴嗪化疗6例(同时加用放疗1例),干扰素和白介素生物治疗13例,中医药辅助治疗3例。有完整随访资料的17例,随访时间3-96个月,平均随访时间34.2个月。结果Ⅱ期患者8例中1例术后91个月局部复发,1例随访19个月后出现骨转移,1例术后12个月腹股沟淋巴结转移,均再次行手术治疗;余5例随访未发现局部复发及远隔转移。Ⅲ期患者12例均行淋巴结清扫术,2例随访肺转移死亡,4例失访,余6例随访无局部复发及远隔转移。Ⅳ期患者2例,1例术后3个月因肺转移死亡。最终完整随访资料的17例患者中13例随诊无进展生存,原病灶局部无复发,植皮或转移皮瓣均成活或经过二期处理后愈合良好。结论肢体黑色素瘤手术治疗后局部肿瘤可得到良好控制,并为肿瘤的综合治疗奠定基础。 Objective To investigate the efficacy of surgical treatment for malignant melanoma of extremity. Methods Retrospective analysis was performed in this study for 22 cases (12 males, 10 females) who were diagnosed with malignant melanoma of extremity in our hospital between August 1993 and December 2007. The mean age was 50.1 years (range, 20-73 years). Of the lesions, 14 located in sole of the foot, 1 in dorsum of the foot, 1 in the second toe, 2 beneath the thumbnail, 3 in soft tissue of the inguinal groove, the thigh and the knee respectively, and 1 in the tibia. According to AJCC Staging system, 8 were in stage II, 12 in stage III, and 2 in stage IV. Extremities of 14 cases were saved, while 8 underwent amputation. Of the cases with limb salvage (n=14), 10 underwent free skin grafting or local flap grafting reconstruction after local excision. 1 with lesion in the tibia was performed resection of tumor segment and prosthetic joint replacement. Of the surgical margin, marginal resection was performed on 4 cases, wide resection on 14 cases, and radical excision on 14 cases. In the second phase, 14 underwent regional lymphadenectomy. After the surgery, Dacarbazine adjuvant chemotherapy was performed on 6 patients (including 1 performed with radiotherapy simultaneously), adjuvant biotherapy of interferon and interleukin on 13 patients, and adjuvant traditional Chinese medicine therapy on 3 patients. Of the follow-up patients, 17 had complete data, with the mean follow-up period being 34.2 months (range, 3-96 months). Results Of the patients in stage II, 1 sustained post-operative local recurrence 91 months, 1 sustained bone metastasis 19 months, and 1 sustained post-operative inguinal metastasis of lymph node. All the 3 patients underwent re-operation. For the other 5 cases in stage II, they had neither local recurrence nor distant metastasis. Of the 12 patients in stage III, all underwent lymphadenectomy. Their follow-up data showed that 2 died from lung metastasis, 4 were withdrawn, and 6 had neither local recurrence nor distant metastasis. Of the 2 cases in stage IV, 1 died from lung metastasis 3 months after surgery. In all, 13 of the follow-up patients (n=17) survived with neither local recurrence nor distant metastasis, and their skin grafting or local flap grafting also survived, or they healed well after processing in the second phase. Conclusions Surgical treatment for malignant melanoma of extremity can well control the local tumor, and establish a good foundation for the comprehensive treatment against tumors.
出处 《中国骨肿瘤骨病》 2010年第4期294-298,共5页 Chinse Journal Of Bone Tumor And Bone Disease
关键词 恶性黑色素瘤 分期 外科治疗 皮瓣 淋巴结清扫 Malignant melanoma Staging Surgical treatment Flap Lymphadenectomy
  • 相关文献

参考文献13

  • 1Thompson JF,Scolyer RA,Kefford RF.Cutaneous melanoma.Lancet,2005,365(9460):687-701.
  • 2Mann GB,Coit DG.Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol,1999,6:263.
  • 3Rager EL,Bridgeford EP,Ollila DW.Cutaneous melanoma:Update on prevention,screening,diagnosis,and treatment.American Family Physician,2005,72:269-276.
  • 4Balch CM,Seng-Jaw Soong,Atkins MB,et al.An evidence-based staging system for cutaneous melanoma.CA Cancer J Clin,2004,54:131-149.
  • 5Devie VT,Hellman S,Rosenberg SA.CANCER:Principles δ Practice of Onology.6th Edition,Lippincott Williams δ Wilkins.USA,2001.
  • 6刘巍峰,牛晓辉.皮肤黑色素瘤的诊断与治疗[J].中国骨肿瘤骨病,2008,7(3):171-175. 被引量:10
  • 7Buzzell RA,Zitelli JA.Favorable prognostic factors in recurrent and metastatic melanoma.J Am Acad Dermatol,1996,34:798-803.
  • 8Mocellin S,Hoon DS,Pilati P,et al.Sentinel lymph node molecular ultrastaging in patients with melanoma:a systematic review and meta-analysis of prognosis.J Clin Oncol,2007,25:1588-1595.
  • 9Keijzer R,Bril H,van der Loo EM,et al.Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma.Ned Tijdschr Geneeskd,2004,148:884-888.
  • 10Dias Moreira R,Altino de Almeida S,Maliska Guimar.es CM,et al.Sentinel node identification by scintigraphic methods in cutaneous melanoma.J Exp Clin Cancer Res,2005,24:181-185.

二级参考文献30

  • 1[1]Rager EL,Bridgeford EP,Ollila DW.Cutaneous melanoma:Update on prevention,screening,diagnosis,and treatment.American Family Physician,2005,72:269-276.
  • 2[2]Devie VT,Hellman S,Rosenberg SA.CANCER:Principles δ practice of onology.6《'th》 Edition.Lippincott Williams δ,Wilkins,USA.2001.
  • 3[3]Averbook B J,Russo L J,Mansonr EG.A long-term analysis of 620 patients with malignant melanoma at a major referral center.Surgery,1998,124:746.
  • 4[4]Roberts DLL,Anstey AV,Barlow RJ.GUIDELINES UK.guidelines for the management o f cutaneous melanoma.Br of Dermatol,2002,146:7-17.
  • 5[5]Garbe C,Eigentler TK.Diagnosis and treatment of cutaneous melanoma:state of the art 2006.Melanoma Research,2007,17:117-127.
  • 6[6]Balch CM,Soong S J,Atkins MB,et al.An evidence-based staging system for cutaneous melanoma.CA Cancer J Clin,2004,54:131-149.
  • 7[7]Buttner P,Garbe C,Bertz J,et al.Primary cutaneous melanoma.Optimized cutoffpoints of minor thickness and importance of Clark's level for prognos-tic classification.Cancer,1995,75:2499.
  • 8[8]Lavie A,Desouches C,Casanova D,et al.Surgical management of cutaneous malignant melanoma.Ann Chir Plast Esthet,2007,52:1-13.
  • 9[9]Albenini JG,Elston DM,Libow LF,et al.Mohs mierographic surgery for melanoma:a case series,a comparative study of immunostains,an informa-tive case report,and a unique mapping technique.Dermatol Surg,2002,28:656-665.
  • 10[10]Sebastian G.Cutaneous malignant melanoma.Excision margins and lymph node dissections.Hautarzt,2006,57:756-763.

共引文献9

同被引文献62

  • 1赵妍,于彬,邓意辉,肖利颖.主动载药法制备硫酸长春新碱脂质体及其包封率的测定[J].中国药学杂志,2005,40(20):1559-1562. 被引量:27
  • 2陈志文,王伟,郭志民,林斌.应用足底内侧皮瓣修复足跟部软组织缺损[J].临床骨科杂志,2006,9(3):236-237. 被引量:10
  • 3康恺,李运曼,蒋轶,方伟蓉.三种黑素瘤动物模型的建立[J].药学进展,2006,30(7):326-329. 被引量:2
  • 4倪东亮,曹杨,陈中.远端蒂腓肠神经营养血管皮瓣静脉回流的解剖与临床对比研究[J].中华显微外科杂志,2007,30(1):55-57. 被引量:47
  • 5Colic M, Morse D. Molecular mechanisms of anti- cancer activity of natural dietetic products [J ]. Colloids Surf,1999,154(1/2) :167-174..
  • 6Le Coutre. Surface planar bilayers of phospholipids used in protein membrance reconstitution: An atom- ic force microscopy stuty[J]. Colloids and Surfaces. B, Biointerfaces,2006,47(1) :102-106.
  • 7Parodi PC, De-Biasio F, Cordaro ER, et al. Distally-based superficial sural flap: advantages of the adipofascial over the fasciocutaneous flap. Scand J Plast Reconstr Surg Hand Surg,2010, 44(1): 37-43.
  • 8Park G, Kim H. Treatment of chronic osteomyelitis using the medial sural perforator flap. J Plast Reconstr Aesthet Surg,2010, 63 (1): 153-159.
  • 9Dragu A, Bach AD, Kneser U, et al. Two easy and simple modifications when using a distally based sural flap to reduce the risk of venous congestion. Plast Reconstr Surg,2008, 122 (2): 683- 684.
  • 10DouglasC Montgomery著 王仁官 陈荣昭译.实验设计与分析[M].北京:中国统计出版社,1998..

引证文献10

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部